Goldman Sachs’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-20,551
| Closed | -$493K | – | 5768 |
|
|
2021
Q4 | $493K | Sell |
20,551
-723
| -3% | -$17.3K | ﹤0.01% | 4535 |
|
|
2021
Q3 | $426K | Buy |
21,274
+19,807
| +1,350% | +$397K | ﹤0.01% | 4476 |
|
|
2021
Q2 | $33K | Sell |
1,467
-579
| -28% | -$13K | ﹤0.01% | 5288 |
|
|
2021
Q1 | $41K | Sell |
2,046
-7,618
| -79% | -$153K | ﹤0.01% | 5156 |
|
|
2020
Q4 | $155K | Buy |
+9,664
| New | +$155K | ﹤0.01% | 4354 |
|
|
2018
Q1 | – | Sell |
-956
| Closed | -$25K | – | 4204 |
|
|
2017
Q4 | $25K | Sell |
956
-210
| -18% | -$5.49K | ﹤0.01% | 4085 |
|
|
2017
Q3 | $44K | Buy |
+1,166
| New | +$44K | ﹤0.01% | 4129 |
|
|
2017
Q1 | – | Sell |
-282
| Closed | -$24K | – | 4426 |
|
|
2016
Q4 | $24K | Buy |
+282
| New | +$24K | ﹤0.01% | 4336 |
|
|
2016
Q2 | – | Sell |
-139
| Closed | -$45K | – | 4529 |
|
|
2016
Q1 | $45K | Buy |
139
+32
| +30% | +$10.4K | ﹤0.01% | 4242 |
|
|
2015
Q4 | $36K | Sell |
107
-2
| -2% | -$673 | ﹤0.01% | 4261 |
|
|
2015
Q3 | $48K | Sell |
109
-191
| -64% | -$84.1K | ﹤0.01% | 4346 |
|
|
2015
Q2 | $166K | Sell |
300
-136
| -31% | -$75.3K | ﹤0.01% | 4106 |
|
|
2015
Q1 | $471K | Buy |
436
+66
| +18% | +$71.3K | ﹤0.01% | 3350 |
|
|
2014
Q4 | $276K | Hold |
370
| – | – | ﹤0.01% | 3757 |
|
|
2014
Q3 | $187K | Sell |
370
-30
| -8% | -$15.2K | ﹤0.01% | 3984 |
|
|
2014
Q2 | $278K | Buy |
+400
| New | +$278K | ﹤0.01% | 3758 |
|